Your browser doesn't support javascript.
loading
Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands.
Nieuwenhuyzen-de Boer, G M; Hofhuis, W; Reesink-Peters, N; Willemsen, S; Boere, I A; Schoots, I G; Piek, J M J; Hofman, L N; Beltman, J J; van Driel, W J; Werner, H M J; Baalbergen, A; van Haaften-de Jong, A M L D; Dorman, M; Haans, L; Nedelcu, I; Ewing-Graham, P C; van Beekhuizen, H J.
Affiliation
  • Nieuwenhuyzen-de Boer GM; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. g.nieuwenhuyzen-deboer@erasmusmc.nl.
  • Hofhuis W; Department of Obstetrics and Gynecology, Albert Schweitzer Hospital, Dordrecht, The Netherlands. g.nieuwenhuyzen-deboer@erasmusmc.nl.
  • Reesink-Peters N; Department of Obstetrics and Gynecology, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.
  • Willemsen S; Department of Obstetrics and Gynecology, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Boere IA; Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands.
  • Schoots IG; Department of Biostatistics, Erasmus MC, Rotterdam, The Netherlands.
  • Piek JMJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Hofman LN; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Beltman JJ; Department of Obstetrics and Gynecology, Catharina Cancer Institute, Eindhoven, The Netherlands.
  • van Driel WJ; Department of Obstetrics and Gynecology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Werner HMJ; Department of Obstetrics and Gynecology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Baalbergen A; Department of Gynecology, Center of Gynecological Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Haaften-de Jong AMLD; Department of Obstetrics and Gynecology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Dorman M; Department of Obstetrics and Gynecology, Reinier de Graaf Gasthuis, Delft, The Netherlands.
  • Haans L; Department of Obstetrics and Gynecology, Haga Hospital, The Hague, The Netherlands.
  • Nedelcu I; Department of Obstetrics and Gynecology, Bravis Hospital, Bergen op Zoom, The Netherlands.
  • Ewing-Graham PC; Department of Obstetrics and Gynecology, Haags Medical Centre, The Hague, The Netherlands.
  • van Beekhuizen HJ; Department of Obstetrics and Gynecology, Groene Hart Hospital, Gouda, The Netherlands.
Ann Surg Oncol ; 29(8): 4833-4843, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35552938

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Ovarian Neoplasms / Plasma Gases Type of study: Clinical_trials / Guideline Aspects: Ethics / Patient_preference Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Ann Surg Oncol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Ovarian Neoplasms / Plasma Gases Type of study: Clinical_trials / Guideline Aspects: Ethics / Patient_preference Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Ann Surg Oncol Year: 2022 Document type: Article